Global Markets for Single Nucleotide Polymorphism Genotyping to Reach $11.5 Billion
Single nucleotide polymorphism or SNPs assume great importance in view of their role in the identification of a person’s ancestry, susceptibility to disease, responsiveness to drugs, side effects experienced and even how he or she looks or acts. They are the most significant group of genetic changes that impact common diseases. Increasing applications of SNPs in numerous areas is expected to drive the future market.
BCC Research provides a detailed study of the global SNP genotyping market through its report, Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets. According to the report, the global SNP genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion by the end of 2014 and $11.5 billion by 2019, with a compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.
Use this report for, but not limited to, the following reasons:
- Gain an overview of the global markets for single nucleotide polymorphism genotyping
- Analyze global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019
- Assess geographic breakdown into the regions of North America, Europe, Asia-Pacific (APAC), and the rest of the world
- Obtain information on the market’s dynamics as well as innovations and current trends
- Analyze the regulatory environment and its impact
- Evaluate market drivers, restraints, and opportunities
- Assess relevant patent analysis
Click here to order your copy of this report (or any of its chapters) or to download the report overview (including the table of contents).
You may be also interested in our other report:
Do email us at scollins@bccresearch.com for any questions pertaining to this report.
Regards,
Sandra Collins
BCC Research LLC,
49 Walnut Park, Building 2
Wellesley, MA 02481, USA
(+1) 781-205-2428
Total Page Views: 961
